![Diagram of QIPCM clinical trial imaging support](/sites/default/files/styles/medium/public/2022-07/1997-QIPCM_ImagingWorkFlow_0.jpg?itok=8Nz_m5h8)
Showing 21 - 30 of 32 results
Université de Sherbrooke
Research on molecular mechanisms associated with cancer.
University Health Network
Provides quality assurance, data management and analysis support for clinical trials to improve consistency and reliability in clinical trial imaging data.
Ontario College of Art and Design University (OCAD University)
Applies system and design thinking strategies to strengthen the resilience of organizations and communities; supports visualization of complex data for purposes of decision making
Université de Sherbrooke
Detection and quantification of RNA and DNA in biological samples
Université de Sherbrooke
Preclinical imaging platform (PET, CT, MRI, optical), radiochemistry and development of new imaging technologies
Image
![CIMS-Centre d'imagerie moléculaire de Sherbrooke](/sites/default/files/styles/large/public/logo/cimslog-1_2_0.jpg?itok=_GBwhkHg)
Université de Sherbrooke
Magnetic resonance imaging (MRI), functional MRI (fMRI), diffusion MRI (dMRI), magnetic resonance spectroscopy, cancer imaging and brain imaging
STTARR Innovation Centre (Spatio-Temporal Targeting and Amplification of Radiation Response Program)
University Health Network
Provides imaging services and technologies for cellular and preclinical research studies.
Image
![ELLICSR](/sites/default/files/styles/large/public/logo/ellicsr-logo.jpg?itok=E51LQgIn)
University Health Network
Innovative survivorship research with practical application to clinical practice, and promoting effective self-management for health and wellness improvement.
University Health Network
Designs, develops and tests new assistive technologies and treatments to enhance the lives of older people and those with disabling injuries or illness
Image
![UHN Princess Margaret Living Biobank](/sites/default/files/styles/large/public/2022-04/Logo.png?itok=SS3tGUWR)
University Health Network
Support resources and services for the use of annotated patient-derived (PD) models including xenografts (PDX) and organoids (PDO) models for research that make an impact in precision cancer medicine.